Archimedes provides researchers, medical professionals, policy makers and executives a valuable alternative to real world clinical research that cannot be studied empirically due to cost, duration, ethics, complexity, number of variables, or urgency.
Ponte Vedra Beach, FL (PRWEB) March 18, 2013
HealthEconomics.Com, recognized for nearly 20 years as the #1 ranked website in health economics, and Archimedes Inc., a healthcare modeling and analytics company, announce plans to continue their digital marketing partnership for 2013. Archimedes is the creator of the Archimedes Model, a carefully validated, clinically-realistic simulation model of health and healthcare.
Archimedes provides researchers, medical professionals, policy makers and executives a valuable alternative to real world clinical research that cannot be studied empirically due to cost, duration, ethics, complexity, number of variables, or urgency. The Archimedes Model can simulate populations, diseases and interventions to create forecast datasets with a high degree of realism and accuracy. Based on current scientific evidence, that is regularly updated and validated, the Archimedes Model can run a virtual clinical trial with 1,000,000 people, spanning 20 years of life in 3 hours.
The HealthEconomics.Com Annual Marketing Partnership Program allows partners to communicate with a global community of 20,000 pharmaceutical, health outcomes research, pricing and reimbursement professionals by offering a tested array of digital marketing solutions. To date, 26 Annual Marketing Partners have signed with HealthEconomics.Com with >90%, like Archimedes Inc., renewing their partnerships for multiple years.
“Archimedes decision to partner with HealthEconomics.Com for a third consecutive year provides us a wonderful opportunity to work with a company that has pioneered health and healthcare modeling systems,” says Dr. Patti Peeples, President and founder of HealthEconomics.Com. “By using the Archimedes Model, researchers can analyze a variety of questions across a large number of biomarkers and interventions, sidestepping the enormous costs, difficulty in obtaining participants, and the investment of time required in real world trials. We look forward to our continued association with Archimedes, and the challenge of promoting the services they offer by creating effective, innovative communication channels that provide access to our global audience of HEOR professionals.”
Archimedes Inc. is located in San Francisco, and was founded by Len Schlessinger, Ph.D, and David Eddy, MD, Ph.D, a pioneer in evidence-based decision making. The Archimedes Model serves as the foundation of innovations such as ARCHeS, the online population simulation and analytics suite and IndiGO, a patient and physician decision support tool to help people understand the implications of their decisions.. For more information on these products, visit the website at http://www.archimedesmodel.com.
About HealthEconomics.Com (http://www.healtheconomics.com): A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.
News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.